about
Identification of Ski as a target for Aurora A kinaseCurrent and future trials of targeted therapies in cutaneous melanomaAurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubulesAurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosisPIM1 kinase as a target for cancer therapyAlisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cellsDNA damage response genes and the development of cancer metastasisAurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cells.The σ2 receptor: a novel protein for the imaging and treatment of cancer.Functional kinomics identifies candidate therapeutic targets in head and neck cancerJadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species-inducing mechanism.Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancerThe proliferation rate paradox in antimitotic chemotherapy.Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family.Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.A novel role for TPX2 as a scaffold and co-activator protein of the Chromosomal Passenger ComplexInhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases.Expression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis.Molecular evidence of cryptotanshinone for treatment and prevention of human cancerThree-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma.Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma.Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases.A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets.Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.Gene expression of Aurora kinases in prostate cancer and nodular hyperplasia tissues.Targeting mitotic pathways for endocrine-related cancer therapeutics.Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition.Cell death response to anti-mitotic drug treatment in cell culture, mouse tumor model and the clinicA new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines.Aurora-A enhances malignant development of esophageal squamous cell carcinoma (ESCC) by phosphorylating β-catenin.Induction of p21CIP1 protein and cell cycle arrest after inhibition of Aurora B kinase is attributed to aneuploidy and reactive oxygen species.A comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model Aurora kinase inhibitorsInvolvement of caspase-2 activation in aurora kinase inhibitor-induced cell death in axin-expressing L929 cells.The impaired viability of prostate cancer cell lines by the recombinant plant kallikrein inhibitor.S39, a novel Aurora B kinase inhibitor, shows potent antineoplastic activity in human Hela cervical cancer cell line.Tetraploidization increases sensitivity to Aurora B kinase inhibition.
P2860
Q24304083-CA27C77C-1FFE-43CC-B609-40D13D6A95EBQ27022355-1DC0EEDD-3AD8-4722-AAF8-55E692868D70Q27677506-890366BF-B74E-4C9D-A83E-D67888613491Q27853047-CA0F06CF-C66A-40ED-8225-534D49DE585FQ28261162-8FA88B7D-8B9F-4191-B0B5-2D6CB2FD27E3Q28386389-B66AFA7A-F339-4F6D-9BA2-2B202C836224Q28388312-6D6E289C-2BA2-4B33-A9C2-9A189C0969ECQ33579079-3F26831A-1248-47E8-A3FC-1EABEE87F3C7Q33782364-A3633B15-0C12-466F-9800-FD5531929087Q34055936-BB216BA0-AB5F-498D-A4DF-E6175A883B75Q35073744-4DDCA8D9-1601-4F9C-89BE-708FB3D269AEQ35356178-753435D9-4F7F-42A4-95A0-D04645001B8CQ35642841-7FA123C8-78CA-4207-85B5-01DCAFE2E988Q35816817-B70595CE-5154-4ADB-AE34-0077F778D4E0Q35889822-CFCD1FFC-416D-4446-8422-101A1F6AE2DCQ35996051-851D8DF7-A938-4BF2-B99F-D5976821E6BBQ36108892-C4C7E73A-3E10-4C20-98E4-91A77CF457EEQ36359519-AF5F3700-39DA-4E7B-95E3-F917098FAC59Q36367628-094E71F2-CF51-48D7-AD4F-194E14AC660DQ36763730-6EB7C33E-17A0-4AAF-86E7-CCC58176ED6CQ36763844-815CDD7A-5C75-4B8C-88D7-8BAF5064A05FQ37259845-80987DE6-E285-4062-86FB-65C9A644F61AQ37279302-5BA6F5F8-F3F0-4280-B73A-66B84D6A972AQ37323073-021362D6-8626-437C-ACBD-AE423838014AQ37593293-3653D38C-D613-45BA-ACB0-7B36333752ACQ37687413-E6725823-FD9C-44C8-8B77-8D0AD8A1B515Q37976467-FA1782E2-6E77-478B-91B9-C029FB595A74Q38298911-220762AA-899B-4C1E-989D-438A7BEBF578Q38400379-31B73585-5930-4D84-969F-8BB5B5FC1792Q38671036-E8839B8B-68B1-4758-A8B0-C1D7762BF3D3Q38835387-7F8756A6-CBE4-41DD-BF09-A5365D4D4AA2Q38935027-4B46DAE3-7179-4A88-A99E-DCDF84438E35Q38944768-8F583D1A-5ACC-4572-82D6-3745DB016DF4Q38957015-38301010-6477-4303-95D7-B55331CB6F09Q39000130-CE688403-AC1C-42C1-8A77-3D358AC9B5E0Q39010396-3CE5E905-9291-4DA1-A200-C7C1CEE7FBB0Q39052359-F86B5B7F-690C-432F-BFF9-B97CC4F76144Q39178333-4660F37F-A8CC-49DE-B5E9-4FC0E45108D6Q39188213-5BBB84C7-AA88-4216-A73E-463CC722D434Q39327085-A06A5B49-BB2F-4D2B-8F54-47B6AAF924A0
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Aurora kinase inhibitors as anticancer molecules.
@ast
Aurora kinase inhibitors as anticancer molecules.
@en
type
label
Aurora kinase inhibitors as anticancer molecules.
@ast
Aurora kinase inhibitors as anticancer molecules.
@en
prefLabel
Aurora kinase inhibitors as anticancer molecules.
@ast
Aurora kinase inhibitors as anticancer molecules.
@en
P2860
P1476
Aurora kinase inhibitors as anticancer molecules.
@en
P2093
Hiroshi Katayama
Subrata Sen
P2860
P304
P356
10.1016/J.BBAGRM.2010.09.004
P407
P577
2010-09-20T00:00:00Z